Earnings ·
Reports Q3 sales of $763.7M, updates full-year revenue guidance to $3.09B and authorizes $500M share buyback increase
GMEDGlobus Medical Inc
Globus Medical reported third-quarter worldwide net sales of $763.7 million, a 0.7% decrease from the prior year period. GAAP diluted earnings per share rose 18.2% to $1.04, while non-GAAP diluted EPS increased 4.4% to $1.23. The company lowered its full-year 2026 revenue guidance to $3.09 billion from a previous range of $3.18 billion to $3.22 billion, though it reaffirmed non-GAAP fully diluted EPS guidance of $4.95 to $5.05. Additionally, the Board authorized an increase of $500 million to its existing share repurchase program, leaving approximately $611 million available for future buybacks as of November 2, 2026. Globus Medical is a leading global musculoskeletal technology company dedicated to solving unmet clinical needs and changing lives.